Mother Issues Urgent Warning Over Hormone Gel Dangers After Daughter's Early Puberty
A mother is issuing a stark warning to parents about the potential risks of accidental exposure to topical hormone gels after her daughter began displaying signs of puberty at just three years old. Samantha Ashworth, 52, describes this traumatic experience as causing her child to "miss out on being a normal child" during crucial early years.
Initial Concerns Dismissed by Medical Professionals
Drawing upon her professional background as a newborn hearing screener and trained nursery nurse, Ms Ashworth recognized the early warning signs when her daughter—now five—began experiencing mood swings and physical changes typically associated with puberty. Despite her expertise and maternal instincts, she felt her concerns were initially dismissed when she first consulted her GP about these worrying developments.
"I knew what it was, but I didn't feel like I was being listened to," Ms Ashworth revealed, highlighting the frustration many parents face when seeking medical answers for their children's unusual symptoms.
Year-Long Journey to Diagnosis
After twelve months of persistent symptoms, numerous missed school days due to medical appointments, and switching between different general practitioners while desperately seeking answers, her daughter finally received a formal diagnosis in February last year. Doctors confirmed she had precocious puberty, a rare condition characterized by the unusually early onset of puberty.
"It was heartbreaking," Ms Ashworth said. "By that time, a full year had passed and she could have been receiving treatment. It was a very stressful and emotional time—we just wanted answers."
Accidental Hormone Exposure Identified as Likely Cause
Medical professionals believe the early onset of puberty may have been triggered by accidental contact with Ms Ashworth's hormone replacement therapy gel, which she uses to manage menopausal symptoms. While transference of topical hormone treatments remains uncommon, it can occur when application instructions are not meticulously followed.
Ms Ashworth described the profound impact on her daughter, who required clothing designed for six to seven-year-olds when she was merely three, as "horrendous." She explained: "Watching her struggle with mood swings and not being able to cope with her emotions at such a young age was awful."
Daily Struggles with Pubertal Symptoms
"Her meltdowns were very hard to manage because it just looked like she was having a tantrum, when in reality, she was dealing with pubescent hormones," the mother continued. "She had uncontrollable outbursts, would take herself off to bed and become very frustrated. It was a daily battle trying to avoid the meltdowns."
Ms Ashworth detailed how her daughter exhibited behaviors typical of teenagers: "Her mood swings were typical of a teenager. She was slamming doors, shouting, crying and not understanding what was going on in her body. She was suffering greatly, but I couldn't explain it to her in a way she would understand."
Expert Warnings About Hormone Potency
Professor Jovanna Dahlgren, a paediatric endocrinology expert at Sahlgrenska University Hospital in Gothenburg, has previously emphasized the dangers hormone treatments can pose to children. Speaking to Swedish newspaper Göteborgs-Posten, she stated: "I don't think people always understand how potent these treatments are. The parents become completely desperate when they understand what has happened."
The professor referenced another concerning case where a ten-year-old boy developed breasts after exposure to a female sex hormone treatment his mother was using, illustrating that this risk extends beyond gender boundaries.
Regulatory Response and Safety Measures
The risk of childhood exposure to hormone medications is recognized in Britain. In 2023, the UK's Medicines and Healthcare products Regulatory Agency received a report of a British child experiencing "increased growth and genital enlargement" following exposure to a testosterone gel used by a parent.
This incident prompted the MHRA to request that manufacturers include explicit warnings on testosterone gels, advising adults to wash hands thoroughly and avoid direct skin-to-skin contact with children. Similar precautions are recommended for women using hormone-based medications for menopause to prevent accidental exposure.
Despite these recommendations, Ms Ashworth revealed she was never advised to wear gloves when applying her gel—a precaution frequently recommended to minimize transference risk. "She could have come into contact with the gel through cuddles with me," she acknowledged with regret.
Rising HRT Usage and Associated Risks
This issue emerges against a backdrop of increasing hormone replacement therapy usage among women. According to NHS data, England witnessed 14.7 million HRT items prescribed in 2024/25, representing an 11 percent increase from the previous year.
Estradiol, the primary and most potent form of human estrogen produced by ovaries during reproductive years, constitutes the most common form used in menopausal hormone therapy. Estradiol gel, marketed under brand names including Oestrogel and Sandrena, serves as a first-line transdermal option for managing menopause symptoms.
The NHS Business Services Authority reports that estradiol gel was the most frequently prescribed HRT item in England during 2024/25, with 1.3 million items dispensed—a 13 percent increase compared with 2023/24.
Medical Perspectives on Precocious Puberty
Discussing the potential link between estrogen gel and early puberty, Dr Deborah Lee of Dr Fox Online Pharmacy explained that precocious puberty may become more prevalent as maternal age rises. "The incidence of premature puberty has been rising for many reasons, including environmental factors and the current epidemic of childhood obesity," she noted.
"It is a very distressing condition for both the child and the parents, which always needs careful assessment and management by a specialist paediatrician," Dr Lee emphasized.
Importance of Following Application Instructions
Dr Lee highlighted that the Summary of Product Characteristics for Estrogel explicitly states there exists a small risk of passive oestradiol transfer when using the gel, and children must avoid contact with treated areas. She further clarified that the gel should be left to dry for five minutes and covered with clothing before any potential contact.
"Although the SPC is primarily for medical professionals, it is available online to all and is not intended to be kept away from patients," Dr Lee explained. "It's vital that doctors and nurses pass key information on how to use any medical product to the patient."
She acknowledged the challenges in busy clinical settings: "In a busy clinic, it's not possible to cover everything and patients do need to read the PIL and follow instructions carefully."
Balancing Treatment Benefits with Safety Precautions
Dr Lee offered a balanced perspective: "It's quite possible this case of precocious puberty could have occurred anyway and was nothing to do with the Estrogel. But there is no way to prove this one way or the other. Women should not fear using Estrogel but must follow the instructions for application and use very carefully."
Ms Ashworth's daughter now attends regular check-ups every six months to monitor her condition, while her mother continues to advocate for greater awareness about the potential risks associated with hormone treatments in households with children.
